Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities:
Net income	$ 679	$ 2,346
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	348	393
Deferred income taxes	152	(823)
Change in fair value of derivative liability	(494)	427
Accretion of financing instruments and amortization of prepaid financing costs	105	105
Compensation expense on employee stock options	14	49
Impairment charge on investment in iBio, Inc.	358	36
Non cash gain on AgroSport LLC investment	(88)
Allowance for doubtful accounts	42	(1)
Gain on disposal of fixed assets	(5)
Changes in operating assets and liabilities:
Accounts receivable	182	(884)
Inventories	(96)	111
Prepaid expenses and other assets	97	(43)
Accounts payable	7	(1,292)
Accrued expenses and other current liabilities	(133)	(27)
Net cash provided by operating activities	1,168	397
Cash flows from investing activities:
Purchase of property and equipment	(247)	(327)
Proceeds from sale of fixed assets	6
Investment in AgroSport LLC	(1)
Net cash used in investing activities	(242)	(327)
Cash flows from financing activities:
Advances under revolving credit facility	41,164	45,385
Repayments of advances under revolving credit facility	(40,945)	(44,919)
Proceeds from sale/lease back	143	158
Proceeds from exercises of stock options		3
Repayments under term notes payable	(959)	(829)
Repayments under capitalized lease obligations	(233)	(131)
Net cash used in financing activities	(830)	(333)
Net increase (decrease) in cash	96	(263)
Cash at beginning of fiscal year	132	395
Cash at end of fiscal year	228	132
Supplemental disclosures of cash flow information:
Interest	800	884
Income taxes	221	366
Supplemental disclosures of non-cash transactions:
Accretion of discount on Convertible Note Payable	39	39
Financing on capitalized lease obligations	$ 53